A Study on the Effect of E5501 (study drug) in Adults with Chronic Immune Thrombocytopenia

Mise à jour : Il y a 4 ans
Référence : EUCTR2011-000830-12

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

Core Study To demonstrate that the efficacy of E5501 (in addition to standard of care) is superior to placebo (in addition to standard of care) for the treatment of adult subjects with chronic immune thrombocytopenia (idiopathic thrombocytopenic purpura) (ITP) as measured by durable platelet response Extension Phase To evaluate the safety and tolerability of long-term therapy with E5501 in subjects with chronic ITP (cITP)


Critère d'inclusion

  • Chronic Immune Thrombocytopenia (Idiopathic Thrombocytopenic Purpura)